LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Time to reconsider thromboembolic risk and anticoagulation in transthyretin cardiac amyloidosis?

Photo by jontyson from unsplash

This article refers to ‘Systemic embolism in amyloid transthyretin cardiomyopathy’ by S. Vilches et al. , pub-lished in Eur J Heart Fail 2022;24: 1 387– 1 396. Click to show full abstract

This article refers to ‘Systemic embolism in amyloid transthyretin cardiomyopathy’ by S. Vilches et al. , pub-lished in Eur J Heart Fail 2022;24: 1 387– 1 396.

Keywords: time reconsider; transthyretin; thromboembolic risk; anticoagulation transthyretin; reconsider thromboembolic; risk anticoagulation

Journal Title: European Journal of Heart Failure
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.